IndiaTickerLatest filing: Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
ObservedCompany dossier
Nath Bio-Genes
NSE:NATHBIOGEN · ISIN INE448G01010
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Nath Bio-Genes
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹36.9 Cr · PAT ₹2.7 Cr.
Exchange XBRLLatest ownership: promoter group 45.60% and public 54.40% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE · investor presentation
Observed
Source filing General Updates - Nath Bio-Genes (India) Limited
NSE · exchange filing
Observed
Source filing Nath Bio-Genes (India) Ltd - 537291 - Financial Results As Of 30Th June 2026.
BSE · financial results
Observed
Archived filing Outcome of Board Meeting - Nath Bio-Genes (India) Limited
NSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹36.9 Cr
- Profit after tax
- ₹2.7 Cr
- EPS
- ₹1.33
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 45.60%
- Public
- 54.40%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL